Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study

AIMS: Tumor electric fields therapy (TTFields) is emerging as a novel anti‐cancer physiotherapy. Despite recent breakthroughs of TTFields in glioma treatment, the average survival time for glioblastoma patients with TTFields is <2 years, even when used in conjugation with traditional anti‐cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Yang, Lin, Liu, Hanjie, Zhou, Dan, Chen, Dikang, Zheng, Xiaoque, Yang, Hui, Li, Chong, Chang, Jiusheng, Wu, Anhua, Wang, Zhifei, Ren, Nianjun, Lv, Shengqing, Liu, Yuyang, Jia, Muyuan, Lu, Jian, Liu, Hongyu, Sun, Guochen, Liu, Zhixiong, Liu, Jialin, Chen, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611775/
https://www.ncbi.nlm.nih.gov/pubmed/34710276
http://dx.doi.org/10.1111/cns.13750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611775/
https://www.ncbi.nlm.nih.gov/pubmed/34710276
http://dx.doi.org/10.1111/cns.13750

Ejemplares similares